141 related articles for article (PubMed ID: 12106951)
1. High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease.
Samra Z; Talmor S; Bahar J
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):189-92. PubMed ID: 12106951
[TBL] [Abstract][Full Text] [Related]
2. Multicenter evaluation of the Clostridium difficile TOX A/B TEST.
Lyerly DM; Neville LM; Evans DT; Fill J; Allen S; Greene W; Sautter R; Hnatuck P; Torpey DJ; Schwalbe R
J Clin Microbiol; 1998 Jan; 36(1):184-90. PubMed ID: 9431944
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.
Rüssmann H; Panthel K; Bader RC; Schmitt C; Schaumann R
Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):115-9. PubMed ID: 17211606
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
Novak-Weekley SM; Hollingsworth MH
Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
[TBL] [Abstract][Full Text] [Related]
5. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.
Snell H; Ramos M; Longo S; John M; Hussain Z
J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364
[TBL] [Abstract][Full Text] [Related]
6. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.
Massey V; Gregson DB; Chagla AH; Storey M; John MA; Hussain Z
Am J Clin Pathol; 2003 Jan; 119(1):45-9. PubMed ID: 12520696
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two enzyme immunoassays for detection of Clostridium difficile toxins A and B in swine.
Anderson MA; Songer JG
Vet Microbiol; 2008 Apr; 128(1-2):204-6. PubMed ID: 18006252
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
[TBL] [Abstract][Full Text] [Related]
11. Comparison of TechLab Clostridium difficile Tox-A enzyme immunoassay and Bartels Prima system toxin-A EIA.
Forward KR; Dalton MT; Kerr E; Paisley N; Cooper G
Diagn Microbiol Infect Dis; 1994 Sep; 20(1):1-5. PubMed ID: 7867292
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.
Mattner F; Winterfeld I; Mattner L
Scand J Infect Dis; 2012 Aug; 44(8):578-85. PubMed ID: 22404319
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease.
Miendje Deyi VY; Vandenberg O; Mascart G; Gning S; Retore P; Douat N; Dediste A
Clin Lab; 2008; 54(1-2):9-13. PubMed ID: 18510038
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.
Kawada M; Annaka M; Kato H; Shibasaki S; Hikosaka K; Mizuno H; Masuda Y; Inamatsu T
J Infect Chemother; 2011 Dec; 17(6):807-11. PubMed ID: 21725661
[TBL] [Abstract][Full Text] [Related]
16. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
Shin BM; Lee EJ; Kuak EY; Yoo SJ
Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
[TBL] [Abstract][Full Text] [Related]
17. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.
Merz CS; Kramer C; Forman M; Gluck L; Mills K; Senft K; Steiman I; Wallace N; Charache P
J Clin Microbiol; 1994 May; 32(5):1142-7. PubMed ID: 8051237
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.
Lozniewski A; Rabaud C; Dotto E; Weber M; Mory F
J Clin Microbiol; 2001 May; 39(5):1996-8. PubMed ID: 11326033
[TBL] [Abstract][Full Text] [Related]
19. Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile?
Gilligan PH
J Clin Microbiol; 2008 Apr; 46(4):1523-5. PubMed ID: 18256226
[TBL] [Abstract][Full Text] [Related]
20. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
Chan EL; Seales D; Drum H
Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
